Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,684,000 | -35.5% | 94,615 | -50.0% | 0.02% | -42.3% |
| Q3 2020 | $7,263,000 | -56.0% | 189,197 | -50.5% | 0.03% | -21.2% |
| Q2 2020 | $16,504,000 | +30.5% | 382,050 | -21.2% | 0.03% | +3.1% |
| Q1 2020 | $12,648,000 | -11.4% | 484,560 | +6.0% | 0.03% | +10.3% |
| Q4 2019 | $14,282,000 | +76.2% | 457,022 | +46.9% | 0.03% | +81.2% |
| Q3 2019 | $8,104,000 | +13.8% | 311,010 | -0.1% | 0.02% | +14.3% |
| Q2 2019 | $7,120,000 | – | 311,284 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |